| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |